Market News

Abbott Labs (ABT)

Abbott Labs on Wednesday reported Q3 earnings of $0.92 beating estimates of $0.90. They also declared a quarterly dividend of $0.40 per share.
Shares soared 3.5% on the news.

Oct 15 · 10:55:00 AM · Source: Market News Video
Track · email · face · Twitter · digg · COMMENTS
by Michael Oliveto

Pfizer Inc. has won U.S. and Canadian regulatory approval for its $68 billion acquisition of Wyeth. The companies plan on closing the deal tomorrow. Pfizer won U.S. clearance after agreeing to sell half of Wyeth’s animal health business to Boehringer Ingelheim GmbH within 10 days of the acquisition’s closing, the Federal Trade Commission said today in a statement.
Pfizer agreed in January to buy Wyeth in a stock-cash transaction that would give it access to the depression treatment Effexor and pneumonia vaccine Prevnar.

Oct 14 · 2:13:00 PM · Source: Bloomberg · Related: Wyeth
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Abbott Labs (ABT)

Abbott Laboratories (ABT) reported a 36% increase in third-quarter profit, exceeding Wall Street expectations. The company also also boosted its financial forecast for 2009. The company's Q3 profit was boosted by higher sales of nutritional products and heart devices and accelerating sales growth for its top drug, arthritis treatment Humira.
Abbott's good news was another factor in the Dow Jones heading to 10,000.

Oct 14 · 11:36:00 AM · Source: Dow Jones News Wire
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter

Previous · Next